May 15, 2006
AMERIPATH ANNOUNCES THE APPOINTMENT OF EDWARD R. UHLEMANN,
M.D., AS DIRECTOR OF GASTROINTESTINAL DIAGNOSTIC SERVICES,
AMERIPATH FLORIDA
FOR IMMEDIATE RELEASE
Palm Beach Gardens, FL, May 15, 2006 — AmeriPath,
Inc., a leading national provider of physician-based anatomic
pathology, dermatopathology, and molecular diagnostic services
to physicians, hospitals, clinical laboratories, and surgery
centers, is pleased to announce the appointment of Edward
R. Uhlemann, M.D. as Director of Gastrointestinal Diagnostics,
AmeriPath Florida. AmeriPath Florida GI diagnostics will
focus on providing primary GI histological services, consultations
on difficult cases, and esoteric testing to assist physicians
in the diagnosis and management of GI and digestive disease.
Dr. Uhlemann will head the current team of GI pathology
specialists in Florida, Scott Y. Sittler and Michael Slattery,
and continue its development and expansion of dedicated
GI specialty services in the state. Dr. Uhlemann offers
over 25 years of experience in anatomic and diagnostic
services, with a concentration on gastroenterology. He
has distinguished himself while serving in several positions
of great trust and responsibility in both the academic
and clinical service arenas. Academically, Dr. Uhlemann
served as an assistant professor of pathology and laboratory
medicine, University of Cincinnati. Clinically, Dr. Uhlemann
served as Chief of Gastroenterology and Chief of Endoscopy,
Orlando Regional Healthcare System; and as Chief of Endoscopy
and Chief of Medicine, Humana Hospital Lucerne (Orlando).
Dr. Uhlemann — the only U.S.-trained and board-certified
gastroenterologist/pathologist with a subspecialty fellowship
in GI pathology — is a graduate of the Johns Hopkins
School of Medicine. Dr. Uhlemann completed two residencies — internal
medicine (gastroenterology subspecialty) at the University
of Florida Medical Center and pathology at the Orlando
Regional Medical Center. He also completed a highly unusual
total of three fellowships — gastroenterology at
the University of Florida Medical Center, gastroenterology
at the National Institutes of Health, and GI pathology
at the University of Cincinnati, with the latter being
under the tutelage of world-renowned pathologist Dr. Cecilia
Fenoglio-Preiser.
Dr. Uhlemann was the CEO and managing partner of a 14-physician,
200-employee group of gastroenterologists and nephrologists.
After 13 years of private practice, he felt the need to
pursue new horizons, choosing pathology because of his
conviction that it is the one field in medicine that provides
constant intellectual challenge. Just prior to joining
AmeriPath, he traveled and worked as an adventure guide,
leading monthly trips to sites in over 100 countries, including
Mt. Kilimanjaro in Tanzania, Machu Picchu in Peru, and
the Himalayas. During his travels, Dr. Uhlemann also took
advantage of the opportunities to live with headhunters
in Borneo and to search for Komodo dragons in the wilds
of Indonesia.
Dr. Larry Cribbett, Executive Managing Director, AmeriPath
Florida stated “I am pleased to welcome Dr. Uhlemann
to the AmeriPath Florida practice. He brings a wealth of
clinical experience to our GI Pathology service. He is
committed to providing the highest quality service possible
for our GI Pathology clients and patients. With his experience
as a Healthcare Leader, I am confident he will guide our
GI Team to great success.”
Bruce Walton, AmeriPath’s President of Anatomic
Pathology, Eastern Region, commented, “We are pleased
and honored that Dr. Uhlemann has joined our team of GI
pathologists. His unique experience, expertise and reputation,
as both a gastroenterologist and GI pathologist, reinforce
the strength and commitment of our medical staff and confirm
AmeriPath’s vision of providing quality GI pathology
services to our referring physicians. As a physician-driven
organization, we understand the needs of clinicians and
the importance of providing specialists in their local
communities. This is what differentiates AmeriPath from
our competition. Our focus continues to be on the local
placement of highly qualified GI pathologists — reinforced
by the resources of a national company — in order
to achieve and maintain a truly unparalleled record of
excellence in support of the medical communities and the
patients we serve.”
 |
AmeriPath, Inc. is a leading national provider of cancer
diagnostics, genomics, and related information services.
The company’s extensive diagnostics infrastructure
includes AmeriPath’s Institute of Gastrointestinal
Pathology and Digestive Disease and its esoteric division
Specialty Laboratories, providing support of clinical
diagnostic and prognostic testing and information services,
including fluorescence in situ hybridization, flow cytometry,
DNA analysis, polymerase chain reaction, molecular genetics,
cytogenetics, and HPV typing.
Media Contacts:
Bruce Walton
President, Anatomic Pathology/Eastern Region
AmeriPath, Inc.
Phone: 1-800-330-6565
Email: bwalton@ameripath.com
Kellie Taylor
kellie@redhouseusa.com
770-475-2103
